18th Annual Outsourcing in Clinical Trials New England 2026
Celebrating 50 years of the Tufts Center for the Study of Drug Development. This special anniversary edition of OCT New England features keynote speaker Ken Getz and exclusive contributions from Tufts CSDD as we recognize five decades of advancing clinical research.
Clario is exhibiting and we’d love to meet up! Stop by our booth #36 to learn how we can provide the expertise and tools needed to achieve your clinical research goals efficiently and effectively.
Session information:
Date: October 28, 2026
Time: 11:45 am – 12:15 pm ET
Stream A: Outsourcing & Clinical Operations
Title: Operationalizing PROs and digital endpoints in early oncology: Faster decisions, better data, stronger Phase III
- Embedding Patient-Reported Outcomes (PROs) early to streamline oncology trial operations and control cost: How PROs in Phase I/II can deliver clearer tolerability and patient-experience data, supporting faster decisions and more efficient Phase III planning.
- Operationalizing digital endpoints (eCOA) for speed, quality, and patient-centricity: Practical strategies for configuring eCOA to accelerate startup, and reduce patient burden.
- Using digital endpoints to enable risk-based oversight and phase-to-phase continuity: How continuous, real-time eCOA data supports centralized/risk-based monitoring, and robustness of regulatory and scientific outcomes.
Speaker
Kelly Dumais, Ph.D.
VP, eCOA Clinical Science and Consulting at Clario
Dr. Dumais is a scientist with over 15 years of experience in behavioral and life science research. She is currently the Vice President of eCOA Clinical Science & Consulting at Clario. Kelly has expertise in the implementation of electronic clinical outcome assessments (eCOA) and the development and validation of patient-reported outcomes (PROs) to support labeling claims. She is a subject matter expert in the development of custom site rater training and participant training for improving accuracy in COA reporting and improving inter-and intra-rater reliability. Furthermore, she has expertise in PRO strategy for oncology clinical trials and has published and presented strategies and outcomes of oncology trials at over 14 conferences and webinars.
Meet with us
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.